Patricio La Rosa

Patricio La Rosa, Head of End-to-End Decision Science at Bayer, brings over 20 years of experience in AI and data science. He discusses how AI optimizes drug development, improving trial planning and patient engagement. The conversation highlights the ethical implications of AI, emphasizing the importance of transparency and trust in clinical settings. Patricio also explores barriers to AI adoption and offers strategies for integrating AI into decision-making processes, drawing valuable lessons from agriculture and retail to enhance healthcare outcomes.